Ticker > Company >

Lotus Eye Hospital share price

Lotus Eye Hospital And Institute Ltd.

NSE: LOTUSEYE BSE: 532998 SECTOR: Hospital & Healthcare Services  34k   61   4

64.12
-3.37 (-4.99%)
BSE: Today, 02:56 PM

Price Summary

Today's High

₹ 68

Today's Low

₹ 64.12

52 Week High

₹ 102

52 Week Low

₹ 44.1

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

133.35 Cr.

Enterprise Value

126.54 Cr.

No. of Shares

2.08 Cr.

P/E

94.77

P/B

2.22

Face Value

₹ 10

Div. Yield

0.78 %

Book Value (TTM)

₹  28.9

CASH

7.04 Cr.

DEBT

0.23 Cr.

Promoter Holding

40.03 %

EPS (TTM)

₹  0.68

Sales Growth

2.48%

ROE

4.98 %

ROCE

7.19%

Profit Growth

-28.52 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year2.48%
3 Year14.2%
5 Year4.64%

Profit Growth

1 Year-28.52%
3 Year22.95%
5 Year32.71%

ROE%

1 Year4.98%
3 Year5.94%
5 Year4.59%

ROCE %

1 Year7.19%
3 Year8.54%
5 Year6.6%

Debt/Equity

0.0039

Price to Cash Flow

23.46

Interest Cover Ratio

20.9786

CFO/PAT (5 Yr. Avg.)

1.75938615274804

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 40.03 0.00
Jun 2024 40.24 0.00
Mar 2024 41.40 0.00
Dec 2023 56.58 0.00
Sep 2023 57.58 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 20.9786.
  • The company has an efficient Cash Conversion Cycle of -46.7774 days.
  • Company has a healthy liquidity position with current ratio of 2.2511.
  • The company has a good cash flow management; CFO/PAT stands at 1.75938615274804.

 Limitations

  • The company has shown a poor revenue growth of 14.2006053439918% for the Past 3 years.
  • Company has a poor ROE of 5.93798219643702% over the past 3 years.
  • The company is trading at a high PE of 94.77.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 12.73 12.03 10.88 12.89 12.91
Total Expenditure 10.92 10.45 10.13 11.23 11.77
Operating Profit 1.81 1.58 0.76 1.66 1.15
Other Income 0.27 0.35 0.4 0.31 0.26
Interest 0.01 0.04 0.03 0.06 0.08
Depreciation 0.89 0.98 1.12 1.06 1.23
Exceptional Items 0.01 -0.01 0 0 0
Profit Before Tax 1.18 0.9 0.01 0.86 0.11
Tax 0.34 0.24 -0.02 0.23 0.01
Profit After Tax 0.85 0.66 0.03 0.62 0.1
Adjusted EPS (Rs) 0.41 0.32 0.01 0.3 0.05

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 40.55 32.37 38.91 47.04 48.21
Total Expenditure 36.57 28.73 32.98 39.35 41.58
Operating Profit 3.98 3.64 5.93 7.69 6.63
Other Income 0.9 0.74 0.89 1.15 1.3
Interest 0.24 0.14 0.21 0.2 0.2
Depreciation 2.5 2.33 2.5 2.98 3.73
Exceptional Items -0.69 0.08 -0.01 0 0.01
Profit Before Tax 1.46 1.99 4.09 5.65 4.01
Tax 0.39 0.42 1.11 1.57 1.1
Net Profit 1.06 1.57 2.98 4.08 2.91
Adjusted EPS (Rs.) 0.51 0.75 1.44 1.96 1.4

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 20.8 20.8 20.8 20.8 20.8
Total Reserves 30.46 31.9 33.81 36.78 38.61
Borrowings 0 0 0 0 0
Other N/C liabilities 0.13 -0.06 0.72 0.03 0.69
Current liabilities 5.87 5.82 5.76 5.19 6.23
Total Liabilities 57.26 58.46 61.08 62.8 66.32
Assets
Net Block 42.67 40.54 44.07 44.18 48.65
Capital WIP 0 0 0 0 0.08
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 4.07 4.31 4.14 2.95 3.55
Other N/C Assets 0 0 0 0.96 0.02
Current Assets 10.52 13.6 12.87 14.71 14.02
Total Assets 57.26 58.46 61.08 62.8 66.32
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 2.15 1.91 4.1 5.65 4.01
Adjustment 1.82 1.78 1.9 2.18 2.89
Changes in Assets & Liabilities 1.27 -0.66 -0.75 -2.04 -0.21
Tax Paid -0.27 -0.3 -0.85 -1.41 -1
Operating Cash Flow 4.97 2.73 4.41 4.39 5.68
Investing Cash Flow -0.68 0.49 -3.94 -2.19 -4.63
Financing Cash Flow 0.13 -0.32 -1.58 -1.71 -3.4
Net Cash Flow 4.42 2.9 -1.1 0.49 -2.35

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 57.58 56.58 41.40 40.24 40.03
kaliannagounder sundaramo... 2.41 2.41 2.41 2.41 2.41
kavetha sundaramoorthy 18.78 18.78 18.78 18.78 18.78
sangeetha s 18.84 18.84 18.84 18.84 18.84
s rajkumar 17.54 16.55 1.36 0.21 -
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 42.42 43.42 58.60 59.76 59.97
k s ramalingam 1.43 - 1.43 1.43 1.43
kalpesh harakhchand gala - - 1.09 1.37 1.49
kovai purani finance priv... 6.33 6.33 6.33 6.33 6.34
llp 0.04 0.04 - 0.13 0.06
mahendran devika 1.97 1.97 1.97 1.97 1.97
rajiv choudhary - - 3.03 3.06 4.11
sangeeta choudhary 1.39 1.39 3.92 3.92 3.92
vramath investment consul... 4.84 4.84 4.84 4.84 4.84
urvija choudhary - - - 1.06 -
vramath financial service... 4.82 4.82 - - -

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Company News

Lotus Eye Hospital and Institute informs about board meeting 4 Nov, 1:09 PM Lotus Eye Hospital and Institute informs about cessation of directors 25 Sep, 2:49 PM Lotus Eye Hospital And Institute informs about disclosure 28 Aug, 2:58 PM Lotus Eye Hospital - Quaterly Results 12 Aug, 6:38 PM Lotus Eye Hospital - Quaterly Results 12 Aug, 6:38 PM Lotus Eye Hospital And Institute informs about trading window closure 28 Jun, 4:47 PM Lotus Eye Hospital And Institute informs about newspaper advertisement 28 May, 5:26 PM Lotus Eye Hospital - Quaterly Results 27 May, 7:04 PM Lotus Eye Hospital - Quaterly Results 27 May, 7:04 PM Lotus Eye Hospital & Institute informs about non-applicability of large corporate entity 20 Apr, 12:25 PM Lotus Eye Hospital and Institute informs about certificate 16 Apr, 12:38 PM Lotus Eye Hospital And Institute informs about compliance certificate 6 Apr, 11:20 AM Lotus Eye Hospital and Institute informs about newspaper publication 16 Feb, 2:53 PM Lotus Eye Hospital - Quaterly Results 14 Feb, 5:42 PM Lotus Eye Hospital And Institute informs about compliance certificate 8 Jan, 4:44 PM Lotus Eye Hospital and Institute informs about merger of RTA 3 Jan, 4:56 PM Lotus Eye Hospital And Institute informs about press release 16 Nov, 2:18 PM Lotus Eye Hospital - Quaterly Results 14 Aug, 11:50 AM Lotus Eye Hospital And Institute informs about new center 5 Jul, 5:14 PM Lotus Eye Hospital and Institute inaugurates new center at Saravanampatti 5 Jul, 4:24 PM Lotus Eye Hospital - Quaterly Results 24 May, 7:11 PM Lotus Eye Hospital - Quaterly Results 24 May, 7:11 PM Lotus Eye Hospital and Institute informs about update on board meeting 17 May, 4:43 PM Lotus Eye Hospital And Institute informs about board meeting 16 May, 4:03 PM Lotus Eye Hospital and Institute informs about clarification on price movement 11 May, 1:24 PM Lotus Eye Hospital And Institute informs about PCS certificate 27 Apr, 4:29 PM Lotus Eye Hospital And Institute informs about reconciliation of share capital audit report 26 Apr, 10:06 AM Lotus Eye Hospital and Institute informs about closure of trading window 30 Mar, 12:10 PM Lotus Eye Hospital And Institute informs about newspaper publication 15 Feb, 12:00 PM Lotus Eye Hospital - Quaterly Results 13 Feb, 6:43 PM Lotus Eye Hospital And Institute informs about certificate 7 Jan, 10:28 AM Lotus Eye Hospital and Institute informs about closure of trading window 31 Dec, 2:45 PM Lotus Eye Hospital And Institute informs about appointment of director 21 Dec, 12:25 PM Lotus Eye Hospital And Institute informs about newspaper advertisement 16 Nov, 9:50 AM Lotus Eye Hospital And Institute informs about board meeting 5 Nov, 2:32 PM Lotus Eye Hospital And Institute informs about final dividend 23 Sep, 4:56 PM Lotus Eye Hospital And Institute informs about newspaper advertisement 1 Sep, 3:24 PM Lotus Eye Hospital And Institute informs about book closure 30 Aug, 4:27 PM Lotus Eye Hospital - Quaterly Results 9 Aug, 5:49 PM Lotus Eye Hospital - Quaterly Results 9 Aug, 5:49 PM Lotus Eye Hospital and Institute informs about board meeting intimation 30 Jul, 11:00 AM Lotus Eye Hospital And Institute informs about closure of trading window 30 Jun, 9:49 AM Lotus Eye Hospital And Institute informs about newspaper publication 27 May, 11:28 AM Lotus Eye Hospital - Quaterly Results 25 May, 8:32 PM Lotus Eye Hospital - Quaterly Results 25 May, 8:32 PM Lotus Eye Hospital And Institute informs about board meeting 16 May, 12:15 PM Lotus Eye Hospital And Institute informs about board meeting 16 May, 10:22 AM Lotus Eye Hospital and Institute informs about non applicability of large entity 30 Apr, 10:40 AM Lotus Eye Hospital And Institute informs about disclosure 18 Apr, 10:36 AM Lotus Eye Hospital And Institute informs about resignation of CFO 26 Mar, 9:36 AM

Lotus Eye Hospital Stock Price Analysis and Quick Research Report. Is Lotus Eye Hospital an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Lotus Eye Hospital and its performance over the period of time. Lotus Eye Hospital stock price today is Rs 64.97.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Lotus Eye Hospital cash from the operating activity was Rs 5.6834 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Lotus Eye Hospital has a Debt to Equity ratio of 0.0039 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Lotus Eye Hospital , the EPS growth was -28.5204 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Lotus Eye Hospital has OPM of 13.760244265182 % which is a bad sign for profitability.
     
  • ROE: Lotus Eye Hospital have a poor ROE of 4.9825 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Lotus Eye Hospital is Rs 64.97. One can use valuation calculators of ticker to know if Lotus Eye Hospital share price is undervalued or overvalued.
Last Updated on:
Brief about Lotus Eye Hospital
X